<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IPWatchdog.com | Patents &amp; Intellectual Property Law</title>
	<atom:link href="https://ipwatchdog.com/feed/" rel="self" type="application/rss+xml" />
	<link>https://ipwatchdog.com/</link>
	<description>Trusted on intellectual property law. News and commentary on patents, innovation policy, trade secrets, copyrights and trademarks.</description>
	<lastBuildDate>Fri, 20 Nov 2026 17:20:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.5</generator>
	<item>
		<title>Patents, Pricing and Competition Shape the Future of Medical Innovation</title>
		<link>https://ipwatchdog.com/2026/11/22/patents-pricing-and-competition-shape-the-future-of-medical-innovation/</link>
					<comments>https://ipwatchdog.com/2026/11/22/patents-pricing-and-competition-shape-the-future-of-medical-innovation/#respond</comments>
		
		<dc:creator><![CDATA[Alden Abbott]]></dc:creator>
		<pubDate>Sun, 22 Nov 2026 17:15:01 +0000</pubDate>
				<category><![CDATA[Antitrust]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[biopharma]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[drug prices]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[medical innovation]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[pharmaceutical patents]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208287</guid>

					<description><![CDATA[<p>At the November 9, 2026, IPWatchdog Life Sciences Masters panel, “Patents, Pricing, Competition and the Future of Medical Innovation,” our discussion kept returning to a practical question: will the rules in place today leave investors and biopharmaceutical companies confident enough to fund the medicines patients may need years from now? That question connects patent protection to much more than the date a patent expires.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/22/patents-pricing-and-competition-shape-the-future-of-medical-innovation/">Patents, Pricing and Competition Shape the Future of Medical Innovation</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/22/patents-pricing-and-competition-shape-the-future-of-medical-innovation/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Other Barks &#038; Bites for Friday, November 20: AG Medina Says Personal Data is Payment for Social Media Use; U.S. Copyright Office Reduces Certain Fee Increases; and WIPO IP Indicators Report Says AI May Be Influencing Filings</title>
		<link>https://ipwatchdog.com/2026/11/20/bites-barks-us-copyright-office-reduces-certain-fee-increases-and-wipo-ip-indicators-report-says-ai-ma/</link>
					<comments>https://ipwatchdog.com/2026/11/20/bites-barks-us-copyright-office-reduces-certain-fee-increases-and-wipo-ip-indicators-report-says-ai-ma/#respond</comments>
		
		<dc:creator><![CDATA[Steve Brachmann]]></dc:creator>
		<pubDate>Fri, 20 Nov 2026 18:15:42 +0000</pubDate>
				<category><![CDATA[Barks and Bites]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[Other Barks and Bites]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208348</guid>

					<description><![CDATA[<p>This week in Other Barks &#038; Bites: the U.S. Copyright Office issues its final rule on agency fees reducing proposed fee increases for certain group registrations and paper notices of termination; Anthropic stock falls 10% the day after its IPO as part of a bad week for tech stocks; the Sixth Circuit affirms the cancellation of trademark damages as an impermissible double recovery in a trade secret case against Ford; and more. </p>
<p>The post <a href="https://ipwatchdog.com/2026/11/20/bites-barks-us-copyright-office-reduces-certain-fee-increases-and-wipo-ip-indicators-report-says-ai-ma/">Other Barks &#038; Bites for Friday, November 20: AG Medina Says Personal Data is Payment for Social Media Use; U.S. Copyright Office Reduces Certain Fee Increases; and WIPO IP Indicators Report Says AI May Be Influencing Filings</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/20/bites-barks-us-copyright-office-reduces-certain-fee-increases-and-wipo-ip-indicators-report-says-ai-ma/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CAFC Affirms Dismissals of Patent Infringement Lawsuits Against Apple, Amazon Web Services and Netflix</title>
		<link>https://ipwatchdog.com/2026/11/19/cafc-affirms-dismissals-patent-infringement-lawsuits-against-apple-amazon-web-services-and-netflix/</link>
					<comments>https://ipwatchdog.com/2026/11/19/cafc-affirms-dismissals-patent-infringement-lawsuits-against-apple-amazon-web-services-and-netflix/#respond</comments>
		
		<dc:creator><![CDATA[Rose Esfandiari]]></dc:creator>
		<pubDate>Thu, 19 Nov 2026 21:28:48 +0000</pubDate>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[Federal Circuit]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[amazon]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[CAFC]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[netflix]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent expiration]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Patent Litigation]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208314</guid>

					<description><![CDATA[<p>The U.S. Court of Appeals for the Federal Circuit (CAFC), in two rulings issued today in Touchmusic Entertainment LLC v. Netflix, Inc. and Touchmusic Entertainment LLC v. Apple Inc. and Amazon Web Services, Inc., affirmed decisions of the U.S. District Court for the Northern District of Illinois dismissing infringement claims Ziklag IP LLC asserted on an expired patent. In the Netflix appeal, the CAFC found no abuse of discretion in the district court’s refusal to allow Ziklag to return the original patent owner, Touchmusic, to the case. In the two appeals involving Apple and Amazon Web Services, Inc. (AWS), the CAFC held that Ziklag was collaterally estopped from contesting a ruling that it never received the right to sue for past damages.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/19/cafc-affirms-dismissals-patent-infringement-lawsuits-against-apple-amazon-web-services-and-netflix/">CAFC Affirms Dismissals of Patent Infringement Lawsuits Against Apple, Amazon Web Services and Netflix</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/19/cafc-affirms-dismissals-patent-infringement-lawsuits-against-apple-amazon-web-services-and-netflix/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>PERA: Where Patent Law and Healthcare Issues Collide</title>
		<link>https://ipwatchdog.com/2026/11/19/pera-where-patent-law-and-healthcare-issues-collide/</link>
					<comments>https://ipwatchdog.com/2026/11/19/pera-where-patent-law-and-healthcare-issues-collide/#comments</comments>
		
		<dc:creator><![CDATA[Sharon Crane]]></dc:creator>
		<pubDate>Thu, 19 Nov 2026 19:15:42 +0000</pubDate>
				<category><![CDATA[Capitol Hill]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[legislation]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent eligibility]]></category>
		<category><![CDATA[Patent Reform]]></category>
		<category><![CDATA[PERA]]></category>
		<category><![CDATA[pharmaceutical patents]]></category>
		<category><![CDATA[Section 101]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208199</guid>

					<description><![CDATA[<p>U.S. Supreme Court opinions in Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association for Molecular Pathology v. Myriad Genetics, Inc., and Alice Corporation Pty. Ltd. V. CLS Bank International et al., produced significant challenges to and unpredictability in obtaining and enforcing patent protection in areas including precision medicine, diagnostics, AI, and pharmaceutical treatments. The Patent Eligibility Restoration Act of 2025 (PERA), S. 1546 and the identical H.R. 3152, seek to address these challenges by rewriting 35 U.S.C. § 101 to eliminate all of these “judicial exceptions to patent eligibility.”</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/19/pera-where-patent-law-and-healthcare-issues-collide/">PERA: Where Patent Law and Healthcare Issues Collide</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/19/pera-where-patent-law-and-healthcare-issues-collide/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
		<item>
		<title>The Intangible Investor: What You Can See Everything Reveals About Invention</title>
		<link>https://ipwatchdog.com/2026/11/19/the-intangible-investor-what-you-can-see-everything-reveals-about-invention/</link>
					<comments>https://ipwatchdog.com/2026/11/19/the-intangible-investor-what-you-can-see-everything-reveals-about-invention/#comments</comments>
		
		<dc:creator><![CDATA[Bruce Berman]]></dc:creator>
		<pubDate>Thu, 19 Nov 2026 17:15:37 +0000</pubDate>
				<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Elizabeth Holmes]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patents]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[Theranos]]></category>
		<category><![CDATA[You Can See Everything]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208266</guid>

					<description><![CDATA[<p>You Can See Everything is a thought-provoking amalgam of fact, flare and creative personality profiling inventor Elizabeth Holmes and her partner, Billy Evans, as she prepares for an 11-year prison sentence for defrauding high-profile investors. While her name is associated with more than 150 patents, it is unclear exactly what she invented and the nature of the value it has generated.  </p>
<p>The post <a href="https://ipwatchdog.com/2026/11/19/the-intangible-investor-what-you-can-see-everything-reveals-about-invention/">The Intangible Investor: What &lt;i&gt;You Can See Everything&lt;/i&gt; Reveals About Invention</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/19/the-intangible-investor-what-you-can-see-everything-reveals-about-invention/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Enforcing IP Rights in Brazil: Why Litigation Is Not Always the First Step</title>
		<link>https://ipwatchdog.com/2026/11/19/enforcing-ip-rights-in-brazil-why-litigation-is-not-always-the-first-step/</link>
					<comments>https://ipwatchdog.com/2026/11/19/enforcing-ip-rights-in-brazil-why-litigation-is-not-always-the-first-step/#respond</comments>
		
		<dc:creator><![CDATA[Sonia Carlos Antonio]]></dc:creator>
		<pubDate>Thu, 19 Nov 2026 12:15:01 +0000</pubDate>
				<category><![CDATA[Antitrust]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Copyright]]></category>
		<category><![CDATA[Courts]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Trademark]]></category>
		<category><![CDATA[cease and desist]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[IP enforcement]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Patent Litigation]]></category>
		<category><![CDATA[trademarks]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208167</guid>

					<description><![CDATA[<p>For foreign companies holding trademarks, patents, industrial designs, or other intellectual property assets in Brazil, detecting an infringement can trigger an almost automatic reaction: filing a lawsuit. Although resorting to the courts is an important tool for protecting intellectual property rights, it does not necessarily need to be the first step.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/19/enforcing-ip-rights-in-brazil-why-litigation-is-not-always-the-first-step/">Enforcing IP Rights in Brazil: Why Litigation Is Not Always the First Step</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/19/enforcing-ip-rights-in-brazil-why-litigation-is-not-always-the-first-step/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AI and Drug Patents: Are Super-Fast Followers a Threat to Pharmaceutical Innovation? &#124; IPWatchdog Unleashed</title>
		<link>https://ipwatchdog.com/2026/11/18/ai-drug-patents-super-fast-followers-threat-pharmaceutical-innovation/</link>
					<comments>https://ipwatchdog.com/2026/11/18/ai-drug-patents-super-fast-followers-threat-pharmaceutical-innovation/#comments</comments>
		
		<dc:creator><![CDATA[Gene Quinn]]></dc:creator>
		<pubDate>Wed, 18 Nov 2026 19:15:44 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Interviews & Conversations]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[IPWatchdog Unleashed]]></category>
		<category><![CDATA[Podcasts]]></category>
		<category><![CDATA[Amgen v. Sanofi]]></category>
		<category><![CDATA[Corey Salsberg]]></category>
		<category><![CDATA[drug patents]]></category>
		<category><![CDATA[Emily Johnson]]></category>
		<category><![CDATA[enablement]]></category>
		<category><![CDATA[enablement requirement]]></category>
		<category><![CDATA[fast followers]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[ip]]></category>
		<category><![CDATA[Kwame Mensah]]></category>
		<category><![CDATA[life sciences]]></category>
		<category><![CDATA[Life Sciences 2026]]></category>
		<category><![CDATA[Nicholas Lanzatella]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patents]]></category>
		<category><![CDATA[pharmaceuticals]]></category>
		<category><![CDATA[podcasts]]></category>
		<category><![CDATA[super-fast followers]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208133</guid>

					<description><![CDATA[<p>This week on IPWatchdog Unleashed, I spoke with Emily Johnson, Nicholas Lanzatella, Kwame Mensah, and Corey Salsberg. This conversation took place on November 9, 2026, at IPWatchdog Studios at the fifth annual Life Sciences Masters™ conference. We examine how artificial intelligence is changing life sciences research and patent strategy. Our focus was on the emergence of super-fast followers, who are competitors positioned to quickly analyze published inventions and rapidly pursue related candidates and patent filings. For an industry built on expensive, uncertain research, the implications reach well beyond faster drafting or more efficient discovery. At stake is the balance between accelerating the development of new medicines and preserving the economic incentives that make pioneering discoveries possible in the first place.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/18/ai-drug-patents-super-fast-followers-threat-pharmaceutical-innovation/">AI and Drug Patents: Are Super-Fast Followers a Threat to Pharmaceutical Innovation? | &lt;i&gt;IPWatchdog Unleashed&lt;/i&gt;</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/18/ai-drug-patents-super-fast-followers-threat-pharmaceutical-innovation/feed/</wfw:commentRss>
			<slash:comments>2</slash:comments>
		
		
			</item>
		<item>
		<title>CAFC Vacates Finding of Non-Infringement Due to District Court’s Failure to Resolve Claim Construction Dispute</title>
		<link>https://ipwatchdog.com/2026/11/18/cafc-vacates-finding-of-non-infringement-due-to-district-courts-failure-to-resolve-claim-construction-dispute/</link>
					<comments>https://ipwatchdog.com/2026/11/18/cafc-vacates-finding-of-non-infringement-due-to-district-courts-failure-to-resolve-claim-construction-dispute/#respond</comments>
		
		<dc:creator><![CDATA[Eileen McDermott]]></dc:creator>
		<pubDate>Wed, 18 Nov 2026 18:15:02 +0000</pubDate>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[District Courts]]></category>
		<category><![CDATA[Federal Circuit]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[CAFC]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Patent Litigation]]></category>
		<category><![CDATA[patentability requirements]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208260</guid>

					<description><![CDATA[<p>The U.S. Court of Appeals for the Federal Circuit (CAFC) on Wednesday vacated a judgment of no infringement and affirmed a validity finding for patent owner Edge Systems LLC. The nonprecedential opinion was authored by Judge Prost and joined by Judges Hughes and Cunningham.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/18/cafc-vacates-finding-of-non-infringement-due-to-district-courts-failure-to-resolve-claim-construction-dispute/">CAFC Vacates Finding of Non-Infringement Due to District Court’s Failure to Resolve Claim Construction Dispute</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/18/cafc-vacates-finding-of-non-infringement-due-to-district-courts-failure-to-resolve-claim-construction-dispute/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>AI-assisted SEP Prosecution to Build Portfolios for Licensing, Sale, or Enforcement</title>
		<link>https://ipwatchdog.com/2026/11/18/ai-assisted-sep-prosecution-to-build-portfolios-for-licensing-sale-or-enforcement/</link>
					<comments>https://ipwatchdog.com/2026/11/18/ai-assisted-sep-prosecution-to-build-portfolios-for-licensing-sale-or-enforcement/#respond</comments>
		
		<dc:creator><![CDATA[Mang Zhu]]></dc:creator>
		<pubDate>Wed, 18 Nov 2026 17:15:26 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Courts]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Licensing]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[artificial intelligence]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Patent Litigation]]></category>
		<category><![CDATA[patent prosecution]]></category>
		<category><![CDATA[SEPs]]></category>
		<category><![CDATA[standard essential patents]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208231</guid>

					<description><![CDATA[<p>Standard-essential patents (SEPs) are among the most valuable assets in today's technology economy. They form the foundation of licensing programs, determine competitive positioning, and increasingly become the center of high-stakes litigation across multiple jurisdictions. Yet one reality remains unchanged: many SEPs that initially appear to be strong eventually fail when scrutinized in court.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/18/ai-assisted-sep-prosecution-to-build-portfolios-for-licensing-sale-or-enforcement/">AI-assisted SEP Prosecution to Build Portfolios for Licensing, Sale, or Enforcement</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/18/ai-assisted-sep-prosecution-to-build-portfolios-for-licensing-sale-or-enforcement/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Federal Circuit Affirms Indefiniteness of Breathable Membrane Patent Claims Over Unspecified Measurement Method</title>
		<link>https://ipwatchdog.com/2026/11/18/federal-circuit-affirms-indefiniteness-breathable-membrane-patent-claims-over-unspecified-measurement-method/</link>
					<comments>https://ipwatchdog.com/2026/11/18/federal-circuit-affirms-indefiniteness-breathable-membrane-patent-claims-over-unspecified-measurement-method/#comments</comments>
		
		<dc:creator><![CDATA[Rose Esfandiari]]></dc:creator>
		<pubDate>Wed, 18 Nov 2026 14:15:09 +0000</pubDate>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[Federal Circuit]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[USPTO]]></category>
		<category><![CDATA[CAFC]]></category>
		<category><![CDATA[indefiniteness]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[inter partes review]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent office]]></category>
		<category><![CDATA[Patentability]]></category>
		<category><![CDATA[patentability requirements]]></category>
		<category><![CDATA[precedential decisions]]></category>
		<category><![CDATA[PTAB]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208229</guid>

					<description><![CDATA[<p>The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday in Cocona, Inc. v. VF Outdoor, LLC, affirming a judgment of the U.S. District Court for the District of Colorado that held three claims of a waterproof, breathable membrane patent invalid as indefinite. Circuit Judge Stark wrote for the court, joined by Circuit Judges Lourie and Stoll, and agreed with the district court that the asserted claims recited a numerical range for moisture vapor transmission rate (MVTR) without specifying a method for measuring it.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/18/federal-circuit-affirms-indefiniteness-breathable-membrane-patent-claims-over-unspecified-measurement-method/">Federal Circuit Affirms Indefiniteness of Breathable Membrane Patent Claims Over Unspecified Measurement Method</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/18/federal-circuit-affirms-indefiniteness-breathable-membrane-patent-claims-over-unspecified-measurement-method/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Patents Pitted Against PBMs in Senate Judiciary Hearing on U.S. Drug Prices</title>
		<link>https://ipwatchdog.com/2026/11/17/patents-pitted-against-pbms-in-senate-judiciary-hearing-on-u-s-drug-prices/</link>
					<comments>https://ipwatchdog.com/2026/11/17/patents-pitted-against-pbms-in-senate-judiciary-hearing-on-u-s-drug-prices/#comments</comments>
		
		<dc:creator><![CDATA[Eileen McDermott]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 22:16:51 +0000</pubDate>
				<category><![CDATA[Capitol Hill]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[PBMs]]></category>
		<category><![CDATA[pharmaceutical patents]]></category>
		<category><![CDATA[pharmacy benefit managers]]></category>
		<category><![CDATA[prescription drug pricing]]></category>
		<category><![CDATA[Senate Judiciary Committee]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208202</guid>

					<description><![CDATA[<p>The full Senate Judiciary Committee today heard from five witnesses who urged senators to take action to curb pharmaceutical industry and pharmacy benefit manager (PBM) practices, which they alternately blamed for high U.S. drug costs. While some senators warned that targeting drug makers could have unintended consequences, most supported moving quickly on legislation they claim would lower prices for U.S. consumers, a claim industry has called a “myth”.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/17/patents-pitted-against-pbms-in-senate-judiciary-hearing-on-u-s-drug-prices/">Patents Pitted Against PBMs in Senate Judiciary Hearing on U.S. Drug Prices</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/17/patents-pitted-against-pbms-in-senate-judiciary-hearing-on-u-s-drug-prices/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Solutions Still in Search of a Problem: Seeing Through False Narratives on Patents on Medicines</title>
		<link>https://ipwatchdog.com/2026/11/17/solutions-still-in-search-of-a-problem-seeing-through-false-narratives-on-patents-on-medicines/</link>
					<comments>https://ipwatchdog.com/2026/11/17/solutions-still-in-search-of-a-problem-seeing-through-false-narratives-on-patents-on-medicines/#respond</comments>
		
		<dc:creator><![CDATA[Kristina M. L. Acri née Lybecker]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 18:15:27 +0000</pubDate>
				<category><![CDATA[Government]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Legislation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[USPTO]]></category>
		<category><![CDATA[biologics]]></category>
		<category><![CDATA[biosimilars]]></category>
		<category><![CDATA[BPCIA]]></category>
		<category><![CDATA[competition]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[opinion]]></category>
		<category><![CDATA[patent portfolios]]></category>
		<category><![CDATA[technology]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208125</guid>

					<description><![CDATA[<p>Critics of the pharmaceutical patent system often claim that manufacturers use large patent portfolios to delay competition. A new paper in the Journal of Law and the Biosciences offers the latest version of that argument, focusing specifically on biologics. The authors compare biologic patent portfolios in the United States, Europe, and Japan. They find that the largest patent portfolios are in the United States—and that biologics are associated with more patents than traditional small-molecule drugs. This may be true, but it does not demonstrate that a problem exists. </p>
<p>The post <a href="https://ipwatchdog.com/2026/11/17/solutions-still-in-search-of-a-problem-seeing-through-false-narratives-on-patents-on-medicines/">Solutions Still in Search of a Problem: Seeing Through False Narratives on Patents on Medicines</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/17/solutions-still-in-search-of-a-problem-seeing-through-false-narratives-on-patents-on-medicines/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CAFC Orders Dismissal of Patent Owner’s Independent Action Seeking to Void Verizon Fee Award</title>
		<link>https://ipwatchdog.com/2026/11/17/cafc-orders-dismissal-of-patent-owners-independent-action-seeking-to-void-verizon-fee-award/</link>
					<comments>https://ipwatchdog.com/2026/11/17/cafc-orders-dismissal-of-patent-owners-independent-action-seeking-to-void-verizon-fee-award/#respond</comments>
		
		<dc:creator><![CDATA[Rose Esfandiari]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 15:15:47 +0000</pubDate>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[Federal Circuit]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[CAFC]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[jurisdiction]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent infringement]]></category>
		<category><![CDATA[Patent Litigation]]></category>
		<category><![CDATA[precedential decisions]]></category>
		<category><![CDATA[verizon]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208178</guid>

					<description><![CDATA[<p>The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Monday in Traxcell Technologies, LLC v. Cellco Partnership, dba Verizon Wireless, vacating a judgment of the U.S. District Court for the Western District of Texas and remanding with instructions to dismiss Traxcell’s independent action for lack of jurisdiction. Traxcell brought the action seeking to void an attorneys’ fee award that the U.S. District Court for the Eastern District of Texas granted to Verizon under 35 U.S.C. Section 285, an award the CAFC had previously affirmed.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/17/cafc-orders-dismissal-of-patent-owners-independent-action-seeking-to-void-verizon-fee-award/">CAFC Orders Dismissal of Patent Owner’s Independent Action Seeking to Void Verizon Fee Award</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/17/cafc-orders-dismissal-of-patent-owners-independent-action-seeking-to-void-verizon-fee-award/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Gilead Wins $69 Million Damages, Permanent Injunction Against Defaulting Defendants in HIV Counterfeiting Ring</title>
		<link>https://ipwatchdog.com/2026/11/17/gilead-wins-69-million-damages-permanent-injunction-against-defaulting-defendants-in-hiv-counterfeiting-ring/</link>
					<comments>https://ipwatchdog.com/2026/11/17/gilead-wins-69-million-damages-permanent-injunction-against-defaulting-defendants-in-hiv-counterfeiting-ring/#respond</comments>
		
		<dc:creator><![CDATA[Steve Brachmann]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 13:15:18 +0000</pubDate>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[District Courts]]></category>
		<category><![CDATA[IP News]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Litigation]]></category>
		<category><![CDATA[Trademark]]></category>
		<category><![CDATA[Biktarvy]]></category>
		<category><![CDATA[counterfeits]]></category>
		<category><![CDATA[damages]]></category>
		<category><![CDATA[Gilead]]></category>
		<category><![CDATA[injunstions]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[Lanham Act]]></category>
		<category><![CDATA[trademarks]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=208215</guid>

					<description><![CDATA[<p>Last Friday, U.S. District Judge Natasha Merle of the Eastern District of New York entered an order adopting a U.S. magistrate judge’s report and recommendation to grant Gilead Sciences’ motion for default judgment against eight individuals and 18 shell companies involved in a conspiracy to market counterfeit HIV treatments, many of them improperly labelled and sold with falsified chain-of-sale documents.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/17/gilead-wins-69-million-damages-permanent-injunction-against-defaulting-defendants-in-hiv-counterfeiting-ring/">Gilead Wins $69 Million Damages, Permanent Injunction Against Defaulting Defendants in HIV Counterfeiting Ring</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/17/gilead-wins-69-million-damages-permanent-injunction-against-defaulting-defendants-in-hiv-counterfeiting-ring/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>China’s Automotive Surge in Brazil Is Reshaping the Patent Landscape</title>
		<link>https://ipwatchdog.com/2026/11/17/chinas-automotive-surge-in-brazil-is-reshaping-the-patent-landscape/</link>
					<comments>https://ipwatchdog.com/2026/11/17/chinas-automotive-surge-in-brazil-is-reshaping-the-patent-landscape/#respond</comments>
		
		<dc:creator><![CDATA[Gustavo Sartori]]></dc:creator>
		<pubDate>Tue, 17 Nov 2026 12:15:30 +0000</pubDate>
				<category><![CDATA[Brazil]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Guest Contributors]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[IPWatchdog Articles]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Technology & Innovation]]></category>
		<category><![CDATA[automotive]]></category>
		<category><![CDATA[Brazilian Patent and Trademark Office]]></category>
		<category><![CDATA[electric vehicles]]></category>
		<category><![CDATA[Guest Contributor]]></category>
		<category><![CDATA[hybrid vehicles]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[intellectual property]]></category>
		<category><![CDATA[patent]]></category>
		<category><![CDATA[patent filings]]></category>
		<category><![CDATA[technology]]></category>
		<guid isPermaLink="false">https://ipwatchdog.com/?p=207986</guid>

					<description><![CDATA[<p>Imports of Chinese electric and hybrid vehicles are transforming Brazil’s automotive market. At the same time, data from the Brazilian Patent and Trademark Office (BPTO) show Chinese companies expanding their patent presence. Together, these trends suggest a new phase of competition in which electrification, software and artificial intelligence (AI) may matter as much as manufacturing scale and dealer networks.</p>
<p>The post <a href="https://ipwatchdog.com/2026/11/17/chinas-automotive-surge-in-brazil-is-reshaping-the-patent-landscape/">China’s Automotive Surge in Brazil Is Reshaping the Patent Landscape</a> appeared first on <a href="https://ipwatchdog.com">IPWatchdog.com | Patents &amp; Intellectual Property Law</a>.</p>
]]></description>
		
					<wfw:commentRss>https://ipwatchdog.com/2026/11/17/chinas-automotive-surge-in-brazil-is-reshaping-the-patent-landscape/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
